US Stock MarketDetailed Quotes
CMND Clearmind Medicine
- 1.3600
- -0.0300-2.16%
Close Nov 1 16:00 ET
- 1.3407
- -0.0193-1.42%
Post 19:00 ET
5.54MMarket Cap-641P/E (TTM)
1.4200High1.3400Low63.98KVolume1.4000Open1.3900Pre Close87.85KTurnover1.79%Turnover RatioLossP/E (Static)4.07MShares6.800052wk High1.59P/B4.85MFloat Cap0.920552wk Low--Dividend TTM3.57MShs Float183.0000Historical High--Div YieldTTM5.76%Amplitude0.9205Historical Low1.3730Avg Price1Lot Size
Clearmind Medicine Key Stats
Quarterly+Annual
YOY
| (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 33.40%1.47M | -21.29%1.3M | -24.50%1.38M | -0.77%4.56M | -105.15%-33.99K | 5.83%1.1M | -3.49%1.66M | 12.22%1.83M | 111.36%4.59M | -38.61%660.13K |
| Selling and administrative expenses | 34.14%1.13M | -26.74%980.55K | -7.14%1.16M | 49.79%3.41M | 96.85%-8.42K | 6.04%838.93K | 63.42%1.34M | -4.27%1.25M | 27.37%2.28M | -136.30%-267.67K |
| -General and administrative expense | 34.14%1.13M | -26.74%980.55K | -7.14%1.16M | 49.79%3.41M | 96.85%-8.42K | 6.04%838.93K | 63.42%1.34M | -4.27%1.25M | 27.37%2.28M | -136.30%-267.67K |
| Research and development costs | 31.04%345.88K | 1.70%322.96K | -61.29%227.48K | -50.68%1.12M | -105.99%-52.54K | 5.17%263.95K | -64.59%317.57K | 76.75%587.63K | 492.34%2.26M | 160.97%877.66K |
| Depreciation amortization depletion | ---- | ---- | ---- | -46.21%26.97K | ---- | ---- | ---- | ---- | 3,194.70%50.14K | ---- |
| -Depreciation and amortization | ---- | ---- | ---- | -46.21%26.97K | ---- | ---- | ---- | ---- | 3,194.70%50.14K | ---- |
| Operating profit | -33.40%-1.47M | 21.29%-1.3M | 24.50%-1.38M | 0.77%-4.56M | 105.15%33.99K | -5.83%-1.1M | 3.49%-1.66M | -12.22%-1.83M | -111.36%-4.59M | 38.61%-660.13K |
| Net non-operating interest income expense | 391.27%85.02K | 469.14%33.96K | 236.25%60.58K | 503.91%42.79K | 114.16%1.5K | 301.62%17.31K | 5.97K | 18.02K | -10.59K | -10.59K |
| Non-operating interest income | 391.27%85.02K | 469.14%33.96K | 236.25%60.58K | ---- | ---- | --17.31K | --5.97K | --18.02K | ---- | ---- |
| Total other finance cost | ---- | ---- | ---- | -503.91%-42.79K | ---- | ---- | ---- | ---- | --10.59K | ---- |
| Other net income (expense) | -232.03%-665.1K | 195.45%398.09K | 293.87%157.12K | -287.48%-1.71M | -552.93%-1.71M | 639.62%503.75K | -413.31%-417.06K | -1,499.93%-81.04K | -1,610.85%-440.26K | -262.14K |
| Gain on sale of security | -228.75%-648.61K | 195.45%398.09K | 293.87%157.12K | -287.48%-1.71M | -552.93%-1.71M | 639.62%503.75K | -413.31%-417.06K | -1,499.93%-81.04K | -2,121.17%-440.26K | ---262.14K |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non- operating income (expenses) | ---16.5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -252.57%-2.05M | 57.84%-871.46K | 38.49%-1.17M | -23.33%-6.22M | -79.67%-1.68M | 49.14%-581.82K | -15.02%-2.07M | -15.72%-1.9M | -129.39%-5.04M | 15.27%-932.86K |
| Income tax | 742.29%42.59K | 296.63%36.76K | 5,856.25%201.5K | -42.75%12.56K | -70.18%6.54K | -6.63K | 9.27K | 3.38K | 21.94K | 21.94K |
| Net income | -264.04%-2.09M | 56.26%-908.22K | 27.99%-1.37M | -23.04%-6.23M | -76.23%-1.68M | 49.72%-575.19K | -15.53%-2.08M | -15.93%-1.9M | -130.38%-5.07M | 13.28%-954.8K |
| Net income continuous Operations | -264.04%-2.09M | 56.26%-908.22K | 27.99%-1.37M | -23.04%-6.23M | -76.23%-1.68M | 49.72%-575.19K | -15.53%-2.08M | -15.93%-1.9M | -130.38%-5.07M | 13.28%-954.8K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -264.04%-2.09M | 56.26%-908.22K | 27.99%-1.37M | -23.04%-6.23M | -76.23%-1.68M | 49.72%-575.19K | -15.53%-2.08M | -15.93%-1.9M | -130.38%-5.07M | 13.28%-954.8K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -264.04%-2.09M | 56.26%-908.22K | 27.99%-1.37M | -23.04%-6.23M | -76.23%-1.68M | 49.72%-575.19K | -15.53%-2.08M | -15.93%-1.9M | -130.38%-5.07M | 13.28%-954.8K |
| Basic earnings per share | 75.72%-0.59 | 98.32%-0.28 | 96.37%-0.9 | 73.66%-30.7892 | 86.57%-2.7705 | 90.63%-2.43 | 59.72%-16.62 | 36.83%-24.8 | -64.35%-116.9127 | 25.93%-20.6357 |
| Diluted earnings per share | 75.72%-0.59 | 98.32%-0.28 | 96.37%-0.9 | 73.66%-30.7892 | 86.57%-2.7705 | 90.63%-2.43 | 59.72%-16.62 | 36.83%-24.8 | -64.35%-116.9127 | 25.93%-20.6357 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data